Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results